Evista
$ 50,00 – $ 361,00Price range: $ 50,00 through $ 361,00
Extra ED Pack
$ 120,00
Exelon
$ 19,00 – $ 299,00Price range: $ 19,00 through $ 299,00
Exelon is a specialized medication primarily used to treat mild to moderate dementia associated with Alzheimer’s disease. This treatment works by increasing the levels of certain natural substances in the brain, which helps improve memory, awareness, and the ability to perform daily tasks. It is also officially indicated for the management of mild to moderate dementia related to Parkinson’s disease. By supporting cognitive function, Exelon assists patients in maintaining their mental clarity and functional independence for a longer period. The medication is available in different forms, including oral capsules and convenient transdermal patches, to suit various patient needs.
Active substance: Rivastigmine
SKU:
Exelon
Category: Dementias
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Exelon belongs to a group of medicines called central cholinesterase inhibitors. It is indicated for the management of mild to moderate dementia of the Alzheimer’s type and dementia associated with Parkinson’s disease. The medication is available in oral and transdermal formulations and is dispensed under medical supervision in accordance with federal regulations.
Therapy requires an individualized dosing schedule with gradual dose titration to achieve pharmacological efficacy while minimizing gastrointestinal adverse effects. Caregivers and patients must adhere strictly to administration guidelines to ensure therapeutic consistency and safety throughout the treatment course.
| Drug Name | Exelon |
| Active Ingredient | Rivastigmine |
| Therapeutic Class | Central Cholinesterase Inhibitor |
| Dosage Form | Oral capsules, oral solution, transdermal system |
| Route of Administration | Oral, Transdermal |
| Prescription Status | Prescription only (Rx) |
Pharmacological Profile and Indications
How the drug works
Rivastigmine functions as a carbamate-selective, reversible inhibitor of both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). In neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease dementia, progressive degeneration of cholinergic neurons in the basal forebrain leads to a deficit in central acetylcholine levels. By inhibiting the enzymes responsible for hydrolyzing acetylcholine within the synaptic cleft, Exelon increases central cholinergic neurotransmission in cortical regions. Unlike cholinesterase inhibitors that exclusively target AChE, rivastigmine exerts dual inhibition against both AChE and BuChE, which may contribute to sustained neurochemical activity in regions affected by neurodegenerative processes.
What happens in the body
Following oral administration, rivastigmine is rapidly and thoroughly absorbed, attaining peak plasma concentrations (Cmax) within approximately 1 hour. Administration with food delays peak absorption by roughly 90 minutes and decreases Cmax by about 30%, while increasing overall area under the curve (AUC) by 30%. Absolute bioavailability for the oral formulation is approximately 36% at a 3 mg dose. Metabolism occurs primarily through cholinesterase-mediated hydrolysis at the target site into a decarbamylated metabolite, exhibiting minimal dependence on liver cytochrome P450 enzymes. The elimination half-life in plasma is approximately 1.5 hours after oral administration, though inhibition of acetylcholinesterase persists significantly longer. Excretion of metabolites occurs mainly via renal pathways, with more than 97% recovered in urine within 24 hours.
Main uses
Exelon is FDA-approved for the treatment of mild to moderate dementia of the Alzheimer’s type. It is also approved for the treatment of mild to moderate dementia associated with Parkinson’s disease. In clinical evaluations, the medication has demonstrated efficacy in maintaining cognitive assessment scores and functional abilities relative to baseline in mild-to-moderate disease stages. It does not arrest the underlying neurodegenerative process or reverse pre-existing neuronal damage. Any clinical application outside of Alzheimer’s dementia or Parkinson’s disease dementia represents an off-label use and requires formal clinical justification by a licensed healthcare provider.
Administration, Safety, and Precautions
Dosing schedule
Oral therapy with Exelon is initiated at a dose of 1.5 mg twice daily, taken with morning and evening meals. If the initial dosage is well tolerated for a minimum of two weeks, the prescriber may increase the dosage to 3 mg twice daily, followed by potential stepwise titration to 4.5 mg twice daily and a maximum oral dosage of 6 mg twice daily. Transdermal patches are applied once daily to intact, hairless skin on the upper or lower back, upper arm, or chest, with application sites rotated daily to reduce localized skin irritation. A single patch must be worn for 24 hours and removed before applying a fresh patch to a different anatomical location to avoid accidental overdose.
Compatibility with other medicines
Exelon interacts with several pharmacological drug classes due to its cholinergic mechanism of action. Co-administration with anticholinergic medications, such as atropine, diphenhydramine, or certain tricyclic antidepressants, can mutually neutralize therapeutic effects. Synergistic pharmacodynamic interactions occur when rivastigmine is combined with other cholinomimetics or succinylcholine-type muscle relaxants utilized during general anesthesia. Concomitant administration with beta-blockers may increase the risk of severe bradycardia and conduction abnormalities. Because metabolism bypasses primary hepatic P450 pathways, classical CYP450 drug interactions are clinically negligible.
Adverse reactions
The safety profile of Exelon is influenced by peripheral and central cholinergic activation. Gastrointestinal side effects are common, particularly during the initial titration period. Reported adverse reactions include:
- Nausea and vomiting
- Diarrhea and abdominal discomfort
- Anorexia and weight loss
- Dizziness and headache
- Bradycardia and syncope
- Application site erythema and irritation (transdermal patch)
Severe vomiting following rapid dose escalation may result in esophageal rupture in rare instances. Patients experiencing severe skin reactions or systemic hypersensitivity should discontinue use and consult their healthcare provider promptly.
Important precautions
Careful clinical evaluation is required before prescribing Exelon to patients with cardiac conduction disorders, including sick sinus syndrome or high-grade atrioventricular block, due to the risk of severe bradycardia and syncopal episodes. Patients with a history of peptic ulcer disease or those receiving concurrent nonsteroidal anti-inflammatory drugs (NSAIDs) require monitoring for gastrointestinal hemorrhage. Cholinergic stimulation can induce bronchoconstriction; therefore, caution is advised in individuals with active asthma or chronic obstructive pulmonary disease (COPD). Low-body-weight patients (under 50 kg) experience a higher incidence of adverse events and require slow titration. Use during pregnancy or breastfeeding should occur only if potential therapeutic benefit justifies the risk to the fetus or nursing infant.
What you may notice early on
During the initial weeks of treatment, mild gastrointestinal symptoms such as nausea or appetite changes may occur as cholinergic receptors adapt to increased acetylcholine concentration. These effects are generally transient and diminish over time with gradual titration schedules. Measurable cognitive or behavioral stabilization typically develops slowly over several weeks to months of continuous compliance, rather than immediately after initiating therapy.
If you skip a dose
If a single oral dose is missed, the patient should skip the missed dose and resume treatment at the next scheduled time without taking additional medication. If treatment is interrupted for more than three consecutive days due to adverse reactions or intercurrent illness, re-initiation must not occur at the previous maintenance dose. Restarting therapy at higher doses after an interruption increases the risk of severe vomiting; treatment must be restarted at the lowest starting dose (1.5 mg twice daily or the lowest patch dose) and re-titrated under medical guidance.
What to avoid while taking it
Oral formulations of Exelon should consistently be taken with food during morning and evening meals to slow drug absorption and improve stomach tolerance. Ethanol consumption should be minimized or avoided, as alcohol can exacerbate central nervous system adverse effects such as somnolence, dizziness, and impaired motor coordination, while worsening gastric mucosal irritation.
Storage and expiration
Exelon capsules and oral solution should be stored at controlled room temperature between 68°F and 77°F (20°C to 25°C), shielded from excess heat, high humidity, and direct sunlight. Transdermal patches must remain sealed inside their protective foil pouches until immediately prior to application. Used patches should be folded in half so the adhesive side sticks to itself prior to safe disposal in standard household trash away from children and pets. Expired or unused formulations must be disposed of according to established local pharmacy take-back programs.
Common questions
Can transdermal Exelon patches be cut to lower the dose?
No, transdermal patches must never be cut, folded, or trimmed. Cutting the patch damages the matrix system, which can cause rapid release of rivastigmine into the bloodstream and result in severe toxicity.
How long does it take to determine if Exelon is effective?
Clinical response to rivastigmine is progressive. While drug absorption occurs within hours, therapeutic assessment of cognitive stabilization or functional support is typically conducted by prescribers after 4 to 12 weeks of consistent maintenance dosing.
What should be done if a transdermal patch falls off early?
If a patch falls off before the 24-hour application period ends, a fresh patch should be applied to a new skin location for the remainder of the day. The routine application schedule should resume at the normal time the following day.
Is it necessary to inform surgical teams about Exelon therapy?
Yes, healthcare providers and anesthesiologists must be notified prior to surgical procedures. As a cholinesterase inhibitor, rivastigmine can prolong the muscle-relaxant effects of succinylcholine during general anesthesia.
Does Exelon cure Alzheimer’s disease?
Exelon does not cure Alzheimer’s disease or stop structural neurodegeneration. It helps manage symptoms by enhancing available acetylcholine to support existing neural function in remaining brain tissue.
Information on this page is for reference and does not replace an assessment by a licensed healthcare professional. In accordance with FDA regulatory standards for prescription pharmaceuticals.
Additional information
| Dosage |
1.5 mg ,3mg ,4.5 mg ,6mg |
|---|---|
| Package |
30 pills ,30 caps ,60 pills ,60 caps ,90 pills ,90 caps ,120 pills ,120 caps ,180 pills ,180 caps ,240 caps ,270 pills ,270 caps ,360 pills ,360 caps |
| Ενεργός Ουσία |
Related products
Aricept
$ 54,00 – $ 264,00Price range: $ 54,00 through $ 264,00
Active substance: Donepezil
More Details
This product has multiple variants. The options may be chosen on the product page
Artane
$ 48,00 – $ 115,00Price range: $ 48,00 through $ 115,00
Active substance: Trihexyphenidyl
More Details
This product has multiple variants. The options may be chosen on the product page
Donamem
More Details
This product has multiple variants. The options may be chosen on the product page
Kemadrin
$ 41,00 – $ 281,00Price range: $ 41,00 through $ 281,00
Active substance: procyclidine
More Details
This product has multiple variants. The options may be chosen on the product page
Melatonin
Anti-Inflammatories, AntiConvulsants, AntiParasitics, Cancer, Dementias, HIV, Migraine, Osteoporosis, Respiratory Tract
$ 46,00 – $ 201,00Price range: $ 46,00 through $ 201,00
Active substance: Melatonin
More Details
This product has multiple variants. The options may be chosen on the product page
Nootropil
$ 30,00 – $ 363,00Price range: $ 30,00 through $ 363,00
Active substance: Piracetam
More Details
This product has multiple variants. The options may be chosen on the product page
Pim-800
$ 43,00 – $ 274,00Price range: $ 43,00 through $ 274,00
Active substance: Paracetamol
More Details
This product has multiple variants. The options may be chosen on the product page
Symmetrel
$ 47,00 – $ 306,00Price range: $ 47,00 through $ 306,00
Active substance: Amantadine
More Details
This product has multiple variants. The options may be chosen on the product page
